Complete remission of recurrent multiple insulin-producing neuroendocrine tumors of the pancreas with somatostatin analogs: a case report and literature review. [PDF]
Tartaglia A +5 more
europepmc +1 more source
Synchronous AML and pancreatic neuroendocrine neoplasm, both successfully treated with somatostatin analogs and decitabine. [PDF]
Ehsanullah S, Trikalinos NA.
europepmc +1 more source
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.
I. Potorac +40 more
semanticscholar +1 more source
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? [PDF]
Merola E +16 more
europepmc +1 more source
J. Cwikła +5 more
semanticscholar +1 more source
Somatostatin analogs in endothelial dysfunction. [PDF]
Barabutis N.
europepmc +1 more source
Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center. [PDF]
Liu J +7 more
europepmc +1 more source
Somatostatin analogs in neuroendocrine tumors with Ki-67 index of ≥10. [PDF]
Braegelmann J +6 more
europepmc +1 more source
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. [PDF]
Fuentes-Fayos AC +9 more
europepmc +1 more source

